| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1026315046 |
| P356 | DOI | 10.1038/SJ.CDD.4402077 |
| P698 | PubMed publication ID | 17186022 |
| P5875 | ResearchGate publication ID | 6614455 |
| P2093 | author name string | Basu A | |
| Shankar E | |||
| Sivaprasad U | |||
| P2860 | cites work | Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner | Q22008727 |
| Roles of tyrosine phosphorylation and cleavage of protein kinase Cdelta in its protective effect against tumor necrosis factor-related apoptosis inducing ligand-induced apoptosis | Q24298245 | ||
| The receptor for the cytotoxic ligand TRAIL | Q24310481 | ||
| BID: a novel BH3 domain-only death agonist | Q24320091 | ||
| Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family | Q24320301 | ||
| TRAIL receptor-2 signals apoptosis through FADD and caspase-8 | Q28142998 | ||
| Pretreatment of acetylsalicylic acid promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by down-regulating BCL-2 gene expression | Q28192323 | ||
| Protein kinase Cepsilon interacts with Bax and promotes survival of human prostate cancer cells | Q28206601 | ||
| Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death | Q28586301 | ||
| FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2 | Q28609079 | ||
| Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane | Q28647586 | ||
| Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis | Q29614983 | ||
| Two CD95 (APO-1/Fas) signaling pathways | Q29619631 | ||
| Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C | Q29620247 | ||
| Type I and type II reactions in TRAIL-induced apoptosis -- results from dose-response studies. | Q33208795 | ||
| TRAIL sensitizes for ionizing irradiation-induced apoptosis through an entirely Bax-dependent mitochondrial cell death pathway | Q33213562 | ||
| Involvement of protein kinase C-delta in DNA damage-induced apoptosis. | Q35644623 | ||
| PKCdelta-mediated regulation of FLIP expression in human colon cancer cells | Q35748448 | ||
| Mechanisms of resistance to TRAIL-induced apoptosis in cancer | Q35954258 | ||
| Differential modulation of the TRAIL receptors and the CD95 receptor in colon carcinoma cell lines. | Q38601765 | ||
| Protein kinase C-epsilon regulates the apoptosis and survival of glioma cells | Q40384737 | ||
| Variable expression of protein kinase C epsilon in human melanoma cells regulates sensitivity to TRAIL-induced apoptosis | Q40435859 | ||
| Upregulation of FLIP(S) by Akt, a possible inhibition mechanism of TRAIL-induced apoptosis in human gastric cancers | Q40609519 | ||
| Protein kinase Cepsilon is oncogenic in colon epithelial cells by interaction with the ras signal transduction pathway | Q41021405 | ||
| A protective role of PKCepsilon against TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in glioma cells | Q43646229 | ||
| Involvement of protein kinase C-delta in DNA damage-induced apoptosis | Q43722376 | ||
| Differential involvement of Bax and Bak in TRAIL-mediated apoptosis of leukemic T cells | Q43902939 | ||
| Tumor-cell resistance to death receptor--induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax. | Q43903493 | ||
| Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells | Q43904534 | ||
| Effect of Bax deficiency on death receptor 5 and mitochondrial pathways during endoplasmic reticulum calcium pool depletion-induced apoptosis | Q44429648 | ||
| Protein kinase C modulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by targeting the apical events of death receptor signaling | Q44550507 | ||
| PKCepsilon controls protection against TRAIL in erythroid progenitors. | Q46706360 | ||
| Oncogenic transformation alters cisplatin‐induced apoptosis in rat embryo fibroblasts | Q71820083 | ||
| Stimulation of the mitogen-activated protein kinase pathway antagonizes TRAIL-induced apoptosis downstream of BID cleavage in human breast cancer MCF-7 cells | Q74355558 | ||
| Proteolytic activation of protein kinase C-epsilon by caspase-mediated processing and transduction of antiapoptotic signals | Q74666995 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 851-860 | |
| P577 | publication date | 2006-12-22 | |
| P1433 | published in | Cell Death & Differentiation | Q2943974 |
| P1476 | title | Downregulation of Bid is associated with PKCepsilon-mediated TRAIL resistance | |
| P478 | volume | 14 |
| Q47131195 | Activation of PKC-ε counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members. |
| Q37289210 | Azadirone, a limonoid tetranortriterpene, induces death receptors and sensitizes human cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) through a p53 protein-independent mechanism: evidence for the role of the ROS-ERK- |
| Q37063421 | Capsazepine, a TRPV1 antagonist, sensitizes colorectal cancer cells to apoptosis by TRAIL through ROS-JNK-CHOP-mediated upregulation of death receptors |
| Q47108799 | Death Receptors: New Opportunities in Cancer Therapy |
| Q33761831 | Essential role for ALCAM gene silencing in megakaryocytic differentiation of K562 cells. |
| Q24633521 | Inhibition of 5-lipoxygenase triggers apoptosis in prostate cancer cells via down-regulation of protein kinase C-epsilon |
| Q40014283 | Inhibition of ERK attenuates autophagy and potentiates tumour necrosis factor-alpha-induced cell death in MCF-7 cells |
| Q40031192 | Inhibition of novel protein kinase C-epsilon augments TRAIL-induced cell death in A549 lung cancer cells |
| Q39964739 | Manipulation of PKC isozymes by RNA interference and inducible expression of PKC constructs |
| Q36819807 | MicroRNA-125a represses cell growth by targeting HuR in breast cancer |
| Q33930946 | NSC109268 potentiates cisplatin-induced cell death in a p53-independent manner |
| Q37975326 | New insights into cancer-related proteins provided by the yeast model |
| Q24617505 | OXER1, a G protein-coupled oxoeicosatetraenoid receptor, mediates the survival-promoting effects of arachidonate 5-lipoxygenase in prostate cancer cells |
| Q39713485 | Ovarian cancer ascites protects from TRAIL-induced cell death through alphavbeta5 integrin-mediated focal adhesion kinase and Akt activation |
| Q33864132 | PKCalpha expression is a marker for breast cancer aggressiveness |
| Q55060633 | Pro-survival role of protein kinase C epsilon in Philadelphia chromosome positive acute leukemia. |
| Q40006116 | Protein kinase C epsilon confers resistance of MCF-7 cells to TRAIL by Akt-dependent activation of Hdm2 and downregulation of p53. |
| Q37109953 | Protein kinase C epsilon: an oncogene and emerging tumor biomarker |
| Q28818259 | Protein kinase C isoforms: Multi-functional regulators of cell life and death |
| Q24324334 | Protein kinase C-epsilon protects MCF-7 cells from TNF-mediated cell death by inhibiting Bax translocation |
| Q41971372 | Protein kinase C: an attractive target for cancer therapy. |
| Q37446199 | Protein kinase Cdelta supports survival of MDA-MB-231 breast cancer cells by suppressing the ERK1/2 pathway |
| Q36002759 | Protein kinase Cepsilon makes the life and death decision |
| Q37219736 | Protein kinase Cepsilon: the mitochondria-mediated signaling pathway |
| Q34074278 | Regulation of prostate cancer cell survival by protein kinase Cepsilon involves bad phosphorylation and modulation of the TNFalpha/JNK pathway |
| Q34762275 | S6 kinase 2 promotes breast cancer cell survival via Akt. |
| Q39091201 | Targeting PKCε by miR-143 regulates cell apoptosis in lung cancer |
| Q38204165 | The Multifunctional Protein Kinase C-ε in Cancer Development and Progression |
| Q35344603 | The expression and role of protein kinase C (PKC) epsilon in clear cell renal cell carcinoma |
| Q38226821 | The role of microRNAs in the regulation of apoptosis in lung cancer and its application in cancer treatment |
Search more.